Literature DB >> 20736111

Head and neck cancer.

Emily Crozier1, Baran D Sumer.   

Abstract

Early detection of upper aerodigestive tract cancer improves prognosis. The primary care physician plays an important role in early detection of these cancers. Most upper aerodigestive tract cancers are squamous cell carcinomas that are linked to tobacco, alcohol, or human papillomavirus exposure. These cancers produce nonspecific symptoms; thus, any persistent oral cavity lesion or neck mass or other unexplainable ear, nose, and throat symptoms should prompt an evaluation for malignancy. Although overall survival has not improved, nonsurgical treatment approaches have led to higher rates of organ preservation and rehabilitation after treatment has improved the quality of life of survivors. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20736111     DOI: 10.1016/j.mcna.2010.05.014

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  11 in total

1.  Analysis of ECOG performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival.

Authors:  Gefter Thiago Batista Corrêa; Gabriela Alencar Bandeira; Bruna Gonçalves Cavalcanti; Francis Balduíno Guimarães Santos; João Felício Rodrigues Rodrigues Neto; André Luiz Sena Guimarães; Desirée Sant'Ana Haikal; Alfredo Maurício Batista De Paula
Journal:  Support Care Cancer       Date:  2012-11       Impact factor: 3.603

2.  Oral squamous cell carcinoma in a pigtailed macaque (Macaca nemestrina).

Authors:  Diane E Stockinger; Derek L Fong; Keith W Vogel; W McIntyre Durning; Anne E Torrence; Timothy M Rose; Jeannette P Staheli; Audrey Baldessari; Robert D Murnane; Renee R Hukkannen
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

3.  Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer.

Authors:  A H Baer; B A Hoff; A Srinivasan; C J Galbán; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-19       Impact factor: 3.825

4.  Signatures of Mucosal Microbiome in Oral Squamous Cell Carcinoma Identified Using a Random Forest Model.

Authors:  Jianhua Zhou; Lili Wang; Rongtao Yuan; Xinjuan Yu; Zhenggang Chen; Fang Yang; Guirong Sun; Quanjiang Dong
Journal:  Cancer Manag Res       Date:  2020-07-03       Impact factor: 3.989

Review 5.  Bioengineering in salivary gland regeneration.

Authors:  Maryam Hajiabbas; Claudia D'Agostino; Julia Simińska-Stanny; Simon D Tran; Amin Shavandi; Christine Delporte
Journal:  J Biomed Sci       Date:  2022-06-06       Impact factor: 12.771

6.  A prospective cohort study of body size and risk of head and neck cancers in the NIH-AARP diet and health study.

Authors:  Arash Etemadi; Mark G O'Doherty; Neal D Freedman; Albert R Hollenbeck; Sanford M Dawsey; Christian C Abnet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-29       Impact factor: 4.254

7.  A Case of Reactive Cervical Lymphadenopathy with Fat Necrosis Impinging on Adjacent Vascular Structures.

Authors:  Albert Y Han; Jacob F Lentz; Edward C Kuan; Hiwot H Araya; Mohammad Kamgar
Journal:  Case Rep Otolaryngol       Date:  2016-10-20

8.  Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma.

Authors:  Hunter John Piegols; Marilia Takada; Maciej Parys; Thomas Dexheimer; Vilma Yuzbasiyan-Gurkan
Journal:  Oncotarget       Date:  2018-09-04

9.  Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Authors:  Tanguy Seiwert; John Sarantopoulos; Howard Kallender; Stewart McCallum; Harold N Keer; George Blumenschein
Journal:  Invest New Drugs       Date:  2012-08-24       Impact factor: 3.850

Review 10.  Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment.

Authors:  Cláudia Viegas; Daniela S M Pereira; Pedro Fonte
Journal:  Materials (Basel)       Date:  2022-03-11       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.